DCIS does not need treatment… really?

Breast Cancer Research and Treatment

Volumn 154, Issue 1, 2015, Pages

  Hughes, Kevin S ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Bermuda Cancer Genetics and Risk Assessment Clinic   (Bermuda)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CONSERVATIVE TREATMENT; EDITORIAL; HUMAN; INTRADUCTAL CARCINOMA; MASTECTOMY; METASTASIS; PARTIAL MASTECTOMY; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT INDICATION; TREATMENT PLANNING; TUMOR INVASION; BREAST TUMOR; FEMALE; MORTALITY;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS;

EID: 84945446376     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-015-3606-x     Document Type: Editorial

References (22)

1. Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P (2015) Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol 1(7):888–896. doi:10.1001/jamaoncol.2015.2510
2. Doubt is raised over value of surgery for breast lesion at earliest stage, New York Times (2015) http://www.nytimes.com/2015/08/21/health/breast-cancer-ductal-carcinoma-insitu-study.html?_r=1. Accessed 29 Sept 2015
3. McDonald P (ed) (2004) Oxford dictionary of medical quotations, 1st edn. Oxford University Press, Oxford
4. Sagara Y, Mallory MA, Wong S et al (2015) Survival benefit of breast surgery for low-grade ductal carcinoma in situ: a population-based cohort study. JAMA Surg 150:739–745
5. Rutgers EJ (2001) Quality control in the locoregional treatment of breast cancer. Eur J Cancer 37:447–453
6. McCormick B, Winter K, Hudis C et al (2015) RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J Clin Oncol 33:709–715
7. Schwartz GF, Veronesi U, Clough KB, et al. (2006) Proceedings of the consensus conference on breast conservation, April 28 to May 1, 2005, Milan. Cancer 107:242–250
8. Lee JW, Han W, Ko E et al (2008) Sonographic lesion size of ductal carcinoma in situ as a preoperative predictor for the presence of an invasive focus. J Surg Oncol 98:15–20
9. Fisher B, Redmond C, Fisher ER et al (1985) Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312:674–681
10. Taghian A, Mohiuddin M, Jagsi R, Goldberg S, Ceilley E, Powell S (2005) Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg 241:629–639
11. Moran MS, Schnitt SJ, Giuliano AE et al (2014) Society of surgical oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol 32:1507–1515
12. Moran MS, Schnitt SJ, Giuliano AE et al (2014) Society of surgical oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Int J Radiat Oncol Biol Phys 88:553–564
13. Silverstein MJ, Lagios MD (2010) Choosing treatment for patients with ductal carcinoma in situ: fine tuning the University of Southern California/Van Nuys prognostic index. J Natl Cancer Inst Monogr 2010:193–196
14. Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–2106
15. Hathout L, Hijal T, Theberge V et al (2013) Hypofractionated radiation therapy for breast ductal carcinoma in situ. Int J Radiat Oncol Biol Phys 87:1058–1063
16. Taghian AG, Kozak KR, Doppke KP et al (2006) Initial dosimetric experience using simple three-dimensional conformal external-beam accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys 64:1092–1099
17. Vaidya JS, Wenz F, Bulsara M et al (2014) Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet 383:603–613
18. Solin LJ, Gray R, Baehner FL et al (2013) A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J Natl Cancer Inst 105:701–710
19. Allred DC, Anderson SJ, Paik S et al (2012) Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. J Clin Oncol 30:1268–1273
20. Rudloff U, Jacks LM, Goldberg JI et al (2010) Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol 28:3762–3769
21. Page DL, Dupont WD, Rogers LW, Landenberger M (1982) Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer 49:751–758
22. Kurniawan ED, Rose A, Mou A et al (2010) Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ. Arch Surg 145:1098–1104